Ebolainfeksjon: Symptomer
Typiske symptomer er plutselig feber, slapphet og muskelsmerter. Etter hvert også hodepine og sår hals. Dette følges av oppkast, diarè, utslett, og sviktende lever og nyrefunksjon. Senere kan det oppstå både indre og ytre blødninger: fra magetarmkanalen, lungene, underlivet, nesen, slimhinnene i munnen og i huden. Blødningene kan føre til sviktende blodsirkulasjon og død.
Annonse
Vil du vite mer
Dette dokumentet er basert på det profesjonelle dokumentet Ebola . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Fabiansen C, Kronborg G, Thybo S, Nielsen JO. Ebola - hæmoragisk feber. Ugeskr Læger 2008; 170: 3949. Ugeskrift for Læger
- World Health Organisation. Situation report. Ebola virus disease. 10 June 2016. apps.who.int
- WHO media centre. Final trial results confirm Ebola vaccine provides high protection against disease. Dec. 23, 2016 www.who.int
- Pourrut X, Delicat A, Rollin PE et al. Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. J Infect Dis 2007; 196: 176-83. PubMed
- Leroy EM, Kumulungui B, Pourrut X et al. Fruit bats as reservoirs of Ebola virus. Nature 2005; 438: 575-6. PubMed
- Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola Virus Disease in Guinea — Preliminary Report. N Eng Journ Med 2014. doi:10.1056/NEJMoa1404505 DOI
- Becquart P, Wauquier N, Mahlakõiv T, et al. High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One 2010; 5: e9126. PubMed
- Thom R, Tipton T, Strecker T, et al. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study. Lancet Infect Dis 2021; 21: 507-16. pmid:33065039 PubMed
- Richardson ET, Kelly JD, Barrie MB, et al. Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey.. PLoS Negl Trop Dis 2016; 11: e0005087. pmid:27846221 PubMed
- Mate SE, Kugelman JR, Nyenswah TG, et al. Molecular Evidence of Sexual Transmission of Ebola Virus. New Engl J Med 2015. doi:10.1056/NEJMoa1509773 DOI
- Deen GF, Knust B, Broutet N, et al. Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors — Preliminary Report. New Engl J Med 2015. doi:10.1056/NEJMoa1511410 DOI
- Zampieri CA, Sullivan NJ, and Nabel GJ. Immunopathology of highly virulent pathogens: insights from Ebola virus. Nat Immunol 2007; 8: 1159-64. PubMed
- Bausch DG, Sprecher AG, Jeffs B et al. Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions. Antiviral Res 2008; 78: 150-61. PubMed
- Bah EI, Lamah MC, Fletcher T, et al. Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea. N Engl J Med. 2014 Nov 5. PMID: 25372658 PubMed
- Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcome in patients with ebola in Sierra Leone. N Engl J Med 2014. doi:10.1056/NEJMoa1411680 DOI
- Mulangu S, Dodd LE, Davey RT, et al. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. N Engl J Med 2019; 381: 2293-303. pmid:31774950 PubMed
- UpToDate.com; Bray M, Chertow DS: Treatment and prevention of Ebola virus disease. Sist oppdatert 28. nov. 2016. www.uptodate.com
- Henao-Restrepo AM, Camacho A, Longini IM, et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet 2016 Dec; Epub ahead of print: S0140-6736(16)32621-6. pmid:28017403 PubMed
- Folkehelseinstituttet. Fakta om ebola og ebolavirussykdom. FHI okt. 2014. [url]http://www.fhi.no/tema/ebola/fakta-om-ebola[/url].,m.,m.,m
- Bowen L, Smith B, Steinbach S, et al. Survivors of Ebola virus disease have persistent neurologic deficits. AAN Annual Meeting Abstract . www.aan.com
- WHO media centre. Fact sheet: Ebola virus disease, last updated January 2016. www.who.int